IL82926A - Human monoclonal antibodies to lav/htlv-iii,cell lines producing them,and pharmaceutical compositions containing them - Google Patents

Human monoclonal antibodies to lav/htlv-iii,cell lines producing them,and pharmaceutical compositions containing them

Info

Publication number
IL82926A
IL82926A IL82926A IL8292687A IL82926A IL 82926 A IL82926 A IL 82926A IL 82926 A IL82926 A IL 82926A IL 8292687 A IL8292687 A IL 8292687A IL 82926 A IL82926 A IL 82926A
Authority
IL
Israel
Prior art keywords
lav
htlv
iii
monoclonal antibodies
human monoclonal
Prior art date
Application number
IL82926A
Other languages
English (en)
Other versions
IL82926A0 (en
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of IL82926A0 publication Critical patent/IL82926A0/xx
Publication of IL82926A publication Critical patent/IL82926A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL82926A 1986-06-23 1987-06-19 Human monoclonal antibodies to lav/htlv-iii,cell lines producing them,and pharmaceutical compositions containing them IL82926A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87757986A 1986-06-23 1986-06-23

Publications (2)

Publication Number Publication Date
IL82926A0 IL82926A0 (en) 1987-12-20
IL82926A true IL82926A (en) 1991-07-18

Family

ID=25370267

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82926A IL82926A (en) 1986-06-23 1987-06-19 Human monoclonal antibodies to lav/htlv-iii,cell lines producing them,and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0251612B1 (de)
JP (1) JP2626680B2 (de)
KR (1) KR910001808B1 (de)
AT (1) ATE103002T1 (de)
AU (1) AU614714B2 (de)
CA (1) CA1339830C (de)
DE (1) DE3789333T2 (de)
DK (1) DK169582B1 (de)
ES (1) ES2050114T3 (de)
IE (1) IE63109B1 (de)
IL (1) IL82926A (de)
PT (1) PT85149B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
JPH02502251A (ja) * 1987-11-13 1990-07-26 ヘルマン　カーティンガー ヒトのモノクローン性抗ｈｉｖ‐１‐抗体
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US5298419A (en) * 1988-03-31 1994-03-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
US5731189A (en) * 1989-02-28 1998-03-24 New York University Human monoclonal antibodies to human immunodeficiency virus
EP0418347A4 (en) * 1989-02-28 1994-12-14 Univ New York Human monoclonal antibodies to human immunodeficiency virus
WO1990010457A1 (en) * 1989-03-14 1990-09-20 New York University Method of treating hiv infections using immunotoxins
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE19809785C2 (de) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmunpharmakon zur Behandlung der HIV-1-Infektion
US6680209B1 (en) * 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
EP3461813A1 (de) 2004-05-23 2019-04-03 Gerard M. Housey Theramuteinmodulatoren
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CA3045756A1 (en) 2015-12-05 2017-06-08 Centre Hospitalier Universitaire Vaudois Hiv binding agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
EP0220273B2 (de) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetische antigene zum nachweis von aids
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
AU8127187A (en) * 1986-12-03 1988-06-09 Ici Australia Operations Proprietary Limited Mine roof supporting element

Also Published As

Publication number Publication date
DK304087A (da) 1987-12-24
JPS63107998A (ja) 1988-05-12
IE63109B1 (en) 1995-03-22
DK304087D0 (da) 1987-06-15
DE3789333D1 (de) 1994-04-21
DE3789333T2 (de) 1994-07-07
EP0251612A3 (en) 1990-05-23
DK169582B1 (da) 1994-12-12
KR910001808B1 (ko) 1991-03-26
EP0251612A2 (de) 1988-01-07
KR880000585A (ko) 1988-03-28
PT85149B (pt) 1990-07-31
IE871587L (en) 1987-12-23
EP0251612B1 (de) 1994-03-16
AU7451287A (en) 1987-12-24
JP2626680B2 (ja) 1997-07-02
ES2050114T3 (es) 1994-05-16
PT85149A (en) 1987-07-01
CA1339830C (en) 1998-04-21
AU614714B2 (en) 1991-09-12
ATE103002T1 (de) 1994-04-15
IL82926A0 (en) 1987-12-20

Similar Documents

Publication Publication Date Title
IL82926A (en) Human monoclonal antibodies to lav/htlv-iii,cell lines producing them,and pharmaceutical compositions containing them
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE2963977D1 (en) Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto
DE3172465D1 (en) Method for the detection of fecal hemoglobin
DE3379116D1 (en) Immunoassay method
DE69133095D1 (de) Cyclosporin-Immunoassay
HUT41836A (en) Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes
KR100215606B1 (en) Toxoplasma gondii antigens, the preparation thereof and the diagnostic agent containing them
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
PT84258A (en) Process for the preparation of cross-protective human monoclonal antibodies and of pharmaceutical compositions containing the same
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
ATE96675T1 (de) Spezifische sekretions-exkretions-antigene von toxoplasma gondii, deren expressionsprodukte, verfahren zu deren herstellung und deren diagnostische und prophylaktische anwendungen.
NZ222560A (en) Method of assaying glucohaemoglobin by converting it to glucitollysine-haemoglobin and assaying it with glucitollysine-specific immunoglobulins
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
FR2601963B1 (fr) Heterohybridomes produisant des anticorps monoclonaux anti-rhesus d humains.
IL83047A0 (en) Monoclonal antibodies to pseudomonas aerigunosa flagella,method and cell line for their production and pharmaceutical compositions containing them
JPS55141452A (en) Synthetic polypeptide
JPS5739350A (en) Preparation of toxoplasma antigen
DE3787121D1 (de) Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen.
EP0556320A4 (en) Monoclonal antibodies to hepatitis c virus and method for using same
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.
EP0207979A4 (de) Immunologisches verfahren zum messen unstabiler analyten unter verwendung kreuzreaktiver antikörper.
IL71877A (en) Process for obtaining monoclonal antibodies directed against tumour antigens and pharmaceutical compositions containing them
JPS5270017A (en) Novel method for immono-assay

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees